Latest Insights on IAS
Market Doldrums; Max Is Back; Tesla: The Next AOL? December 29, 2020 Great Stuff
Fly, My Pretties! Well, Great Ones, it finally happened. The rest of the Great Stuff team ran to the hills this week (probably galloping hard on the plains, if I had to wager). Even my winged monkeys find their way out of Oz eventually… So, it’s just me here holding down the fort at Great […]
Bouncing Biotechs; STAYing Power; Crypto Keynotes December 10, 2020 Great Stuff
Oh, Donna… Welcome back to Great Stuff’s Reader Feedback! As many of you already know, today is all about you the Great Stuff reader … or as we like to call you, the Great Ones. Pretty catchy, huh? Thought that up all by myself. Anyway, today we have questions and rants from David G. on […]
Valuate This! Cinema Showdown; DocuSigned, Sealed, Delivered December 4, 2020 Great Stuff
Friday Four Play: The “Red, Red Whine” Edition I’m feeling a bit ranty today, Great Ones. You’ve been warned. Yesterday, I talked about Chinese electric vehicle (EV) maker Kandi Technologies (Nasdaq: ) and the concerns I have with investing in the stock. One of those concerns is the Holding Foreign Companies Accountable Act, which would […]
Profit From Biotech Innovation in 2021 November 24, 2020 Investment Opportunities, Technology, Winning Investor Daily
Medical innovation is helping us live longer. Biotech is at the forefront of this. You owe it to yourself to profit from it. 
Pfizer Pforfeit; A Nio Dealio; Uber’s Hail Mary November 16, 2020 Great Stuff
Born to Run In the day, we sweat it out on Wall Street. It’s a runaway American dream. At night, we’re locked in mansions of glory, no more suicide machines. But all that might be about to change… Sprung from Phase 3 on highway nine, Moderna’s new injection is stepping out over the line. (Woah!) […]MEET OUR EXPERTS
Editor of Strategic Fortunes and three elite services
Director of VIP Services
Editor of Alpha Investor
Research Analyst
Chief Investment Strategist of Money & Markets
